Bcg vaccine

N/A

100-800 MIL CFU For InjectionUnited StatesMarketedAuthorised 21 Jun 1989

In other countries

The same active substances on other registers, the same brand first.

OncoticeItaly · Polvere per sospensione iniettabile · MSD Italia S.R.L.Same form
BCG vaccin AJV, 0,75 mg per ml, poeder en oplosmiddel voor suspensie voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · AJ Vaccines A/SSame form
Vacina BCGBrazil · Fundacao Ataulpho de PaivaSame substance
Vacina BCGBrazil · Uno Healthcare Comércio de Medicamentos Ltda.Same substance
ImmucystBrazil · Sanofi Pasteur LtdaSame substance
OncoticeCanada · 800000000 UNIT / VIAL · Powder For Solution · Merck Canada INCSame substance
Verity-BCGCanada · 40 MG / VIAL · Powder For Suspension · Verity Pharmaceuticals INC.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bcg vaccine

N/A

100-800 MIL CFU For InjectionUnited StatesMarketedAuthorised 21 Jun 1989

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

BCG TherapeuticCanada · 27 MG / VIAL · Powder For Solution · Connaught Laboratories LTD.

BCG MedacItaly · Polvere e solvente per sospensione endovescicale · Medac Gesellschaft Fur Klinische Spezialpraparate MBH

VesicultureItaly · Polvere per sospensione endovescicale · Aj Vaccines A/S

BCG-medac, poeder en oplosmiddel voor suspensie voor intravesicaal gebruikNetherlands · Poeder voor blaasspoeling · Medac Gesellschaft für klinische Spezialpräparate mbH

BCG Synthaverse 100 mg, poeder voor suspensie voor intravesicaal gebruikNetherlands · Poeder voor blaasspoeling · Synthaverse S.A.

BCG-medacSerbia · 2x10exp8 do 3x10exp9 jedinica formiranja kolonija (CFU)/bočici · prašak i rastvarač za intravezikalnu suspenziju · Quatalia D.O.O.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Bcg vaccine
Strength: 100-800 MIL CFU
Dosage form: For Injection
Route: Percutaneous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 21 Jun 1989
Registration: BLA 103050
Marketing authorisation holder: Merck Teknika LLC
Procedure: 351(a)
Supply: Rx